1
April20 Myths About ADHD Medication Pregnancy: Debunked
ADHD Medication During Pregnancy and Breastfeeding
Women suffering from ADHD face a difficult decision about whether to continue or stop taking ADHD medication during pregnancy and breastfeeding. There is a lack of information about how long-term exposure to these medications may affect the fetus.
A recent study published in Molecular Psychiatry demonstrates that children exposed to ADHD medication during pregnancy do not develop neurological problems like hearing loss or vision, febrile seizures, or IQ impairment. The authors acknowledge the need for more high-quality research.
Risk/Benefit Analysis
Women who are pregnant and taking ADHD medication must evaluate the benefits of using it against the possible dangers for the fetus. Physicians don't have the data to provide clear recommendations, but can provide information about risks and benefits to assist pregnant women to make informed choices.
A study published in Molecular Psychiatry found that women who used ADHD medications during their early pregnancy did not have a significantly increased risk of fetal heart malformations or major structural birth defects. Researchers used a vast population-based case-control study to determine the prevalence of major structural birth defects in babies born to mothers who took stimulants during early pregnancy, and those who did not. Pediatric cardiologists, clinical geneticists and other experts reviewed the cases in order to confirm that the classification was correct and to reduce any bias.
However, the researchers' study had its limitations. The most common adhd medication Uk important issue was that they were unable to distinguish the effects of the medication from the disorder that is underlying. That limitation makes it difficult to know whether the small differences observed in the groups that were exposed result from medication use or confounding by comorbidities. Researchers also did not examine the long-term effects for the offspring.
The study did show that infants whose mothers took ADHD medication for adhd during pregnancy were at a higher risk of being admitted to the neonatal intensive care unit (NICU) than infants who whose mothers did not take any medication or had stopped their medications before or during pregnancy. The reason for this was central nervous system-related disorders and the increased risk for admission was not found to be influenced by the stimulant medications were used during pregnancy.
Women who were taking stimulant ADHD medications during pregnancy also had a higher chance of having an emergency caesarean section or having a baby that scored low on the Apgar scale (less than 7). These increases appear to be unrelated to the type of medication taken during pregnancy.
The research suggests that the risk of a small amount with the use of ADHD medications during early pregnancy may be offset by the higher benefit for both mother and child of continuing treatment for the woman's condition. Physicians should talk to their patients about this and as much as possible, assist them develop coping strategies that can lessen the impact of her disorder in her daily life and relationships.
Medication Interactions
As more women than ever before are being diagnosed with adhd medication uk and treated with medication, the dilemma of whether to continue or discontinue treatment during pregnancy is a question that more and more doctors face. The majority of these decisions are made without solid and reliable evidence in either case, which means that doctors must weigh their knowledge from their own experiences, those of other doctors, and what the research says on the topic as well as their own judgments for each patient.
The issue of possible risks to the infant can be particularly tricky. The research on this subject is based on observation rather than controlled studies and the results are conflicting. Furthermore, most studies restrict their analysis to live births, which could underestimate the severity of teratogenic effects that could cause abortion or termination of the pregnancy. The study presented in the journal club addresses these limitations by analyzing both information on deceased and live births.
The conclusion: While some studies have found a positive association between ADHD medications and the possibility of certain birth defects, others have found no connection and the majority of studies demonstrate a neutral or slight negative effect. As a result, a careful risk/benefit analysis must be conducted in every case.
It can be difficult, if not impossible for women suffering from ADHD to stop taking their medication. In a recent article published in Archives of Women's Mental Health by psychologist Jennifer Russell, she notes that stopping ADHD medications during pregnancy can lead to depression and feelings of loneliness. Furthermore, a loss of medication can affect the ability to do work-related tasks and safely drive, which are important aspects of daily life for a lot of people with ADHD.
She suggests that women who are unsure whether to take the medication or stop due to pregnancy, educate their family members, colleagues, and their friends about the condition, its impact on daily functioning and the benefits of keeping the current treatment plan. It can also aid in ensuring that the woman feels supported when she is struggling with her decision. Some medications can pass through the placenta. If a woman decides to not take her ADHD medication while pregnant and breastfeeding, it is crucial to be aware that the drug may be transferred to her baby.
Risk of Birth Defects
As the use of ADHD medications to treat symptoms of attention deficit hyperactivity disorder (ADHD) increases as do concerns about the effects that the drugs might have on foetuses. A study that was published in the journal Molecular Psychiatry adds to the existing knowledge on this subject. Utilizing two huge data sets, researchers were able to examine more than 4.3 million pregnancies and see whether stimulant medications increased the risk of birth defects. Researchers discovered that although the risk overall is low, the first trimester ADHD medication exposure was associated with slightly higher rates of certain heart defects, such as ventriculoseptal defect.
The researchers behind the study found no connection between the use of early medications and other congenital abnormalities, such as facial clefting or club foot. The results are in line with previous studies that have shown an increase, but not significant, in the risk of cardiac malformations among women who began taking ADHD medications prior to pregnancy. The risk grew during the latter part of pregnancy, as many women decide to stop taking their ADHD medication.
Women who used ADHD medications during the first trimester of pregnancy were also more likely to have caesarean sections, a low Apgar score after delivery and a baby that required help breathing at birth. However, the authors of the study were not able to eliminate bias due to selection by limiting the study to women who didn't have any other medical conditions that could have contributed to these findings.
The researchers hope that their research will serve to inform the clinical decisions of physicians who encounter pregnant women. The researchers advise that while discussing risks and benefits are important, the choice about whether to continue or stop medication should be made in light of the severity of each woman's ADHD symptoms and her needs.
The authors warn that, even though stopping the medication is an option to look into, it is not advised due to the high prevalence of depression and other mental problems in women who are expecting or who have recently given birth. Further, research shows that women who stop taking their medications will have a tough transitioning to life without them after the baby is born.
Nursing
It can be a stressful experience becoming a mother. Women suffering from ADHD can face severe challenges when they must deal with their symptoms, attend doctor appointments and prepare for the birth of their child and adjust to new routines. Therefore, many women choose to continue taking their ADHD medications throughout the course of pregnancy.
The majority of stimulant medications are absorbed by breast milk in low amounts, so the risk for breastfeeding infant is minimal. The amount of exposure to medications can vary depending upon the dosage the medication is administered, its frequency and the time of the day. In addition, different drugs enter the infant's system via the gastrointestinal tract, or through breast milk. The impact of these medications on the health of a newborn is not completely comprehended.
Due to the absence of research, some doctors may be inclined to discontinue stimulant medication during the course of pregnancy. This is a complicated decision for the patient, who must balance the benefits of keeping her medication against the possible dangers to the embryo. As long as more information is available, doctors may inquire about pregnant patients whether they have an history of ADHD or if they intend to take medication in the perinatal stage.
A growing number of studies have shown that the majority of women are able to safely continue their adhd without medication medication during pregnancy and breastfeeding. In response, a rising number of patients are opting to continue their medication. They have discovered through consultation with their doctor that the benefits of continuing their current medication far outweigh any potential risks.
Women who suffer from ADHD who are planning to nurse should seek advice from an expert psychiatrist prior to becoming pregnant. They should discuss the medication they are taking with their physician and discuss the pros and cons for continuing treatment. This includes non-pharmacological strategies. Psychoeducation is also necessary to help pregnant women suffering from ADHD recognize the signs and underlying disorder. They should also be informed about treatment options and strengthen strategies for coping. This should be a multidisciplinary approach with the GPs, obstetricians, and psychiatrists. Counselling for pregnancy should include the discussion of a treatment plan for both mother and child, and monitoring for signs of deterioration and when necessary, making adjustments to the medication regimen.
Reviews